a developer of therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with PTGX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then PTGX could also see price increases.
Ticker / NAME | Correlation To ARDX | 1D Price Change % | ||
---|---|---|---|---|
ARDX | 100% | -1.96% | ||
PTGX - ARDX | 42% Loosely correlated | -1.16% | ||
HRTX - ARDX | 41% Loosely correlated | -5.47% | ||
BCRX - ARDX | 41% Loosely correlated | -2.30% | ||
NKTX - ARDX | 41% Loosely correlated | -4.59% | ||
VTGN - ARDX | 39% Loosely correlated | -3.75% | ||
More |
Ticker / NAME | Correlation To ARDX | 1D Price Change % |
---|---|---|
ARDX | 100% | -1.96% |
gastroenterological theme (2 stocks) | 65% Loosely correlated | +3.63% |
therapeutics theme (53 stocks) | 42% Loosely correlated | -2.44% |
drugs theme (254 stocks) | 40% Loosely correlated | -1.72% |
metabolic theme (5 stocks) | 40% Loosely correlated | -1.40% |
cardiovascular theme (11 stocks) | 36% Loosely correlated | -0.69% |
More |